Psychcast

In this edition of the Psychcast, Joseph Pierre, MD, returns for part II of his talk with Dr. Lorenzo Norris. This time, they discuss how to avoid clinical errors. And later, Dr. RK asks "where are they now?"

Dr. Pierre is health sciences clinical professor in the department of psychiatry and behavioral sciences at the David Geffen School of Medicine at the University of California, Los Angeles.

What is the ideal treatment for patients with dual diagnoses -- what is the real-world treatment? Dr. Lorenzo Norris returns to the MDedge psychcast this week to discuss dual diagnoses. His guest is Dr. Joseph M. Pierre, MD, health sciences clinical professor in the department of psychiatry and behavioral sciences at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Pierre recently published an article for MDedge Psychiatry on the real-world challenges in managing these patients. Dr. Norris and Dr. Pierre discuss ideal treatment compared to real-world treatment. Next week in part II, Dr. Norris and Dr. Pierre dive into addressing malingering and avoiding clinical errors. And Dr. RK joins us to give a talk about, well, words.

In Episode 20, Suma Chand, PhD, stops by to talk about cognitive-behavioral therapy for depression. Dr. Chand dives into the evidence supporting the use of cognitive-behavioral therapy both as monotherapy and in combination with antidepressants for acute and long-term treatment of depression. Dr. Chand previously joined us to talk about how to adapt cognitive-behavioral therapy for older adults. And later, Dr. RK wants you to embrace the suck.

In this edition of the MDedge psychcast, Michael Gitlin, MD, of UCLA discusses the current role of stimulants in psychiatry. Dr. Gitlin raises a number of topics including ADHD and bipolar disorder. In recent years, more data have become available about patients with bipolar who are taking mood stabilizers. And Dr. RK notes the differences in therapy and psychiatry. She says that the profession has work to do on this front.

In this edition of the MDedge psychcast Laura Marsh, MD, returns to discuss Parkinson's disease. And later, the Dr. RK gives part 2 in her talk on HIPPA.

Lorenzo Norris, MD, editor in chief of MDedge Psychiatry, sits down with Igor Galynker, MD, PhD, to talk about an evaluation model he and his team created aimed at assessing the risk of imminent suicide. Dr. Galynker also discusses ways clinicians can assess their own personal emotional responses to patients who are at risk.

Laura Marsh of Baylor College of Medicine joins this episode to discuss manifestations of epilepsy. And later, Dr. Renee Kohanski begins a series into HIPPA.

In this edition, Charles L. Raison, MD, explores how ketamine impacts depression. He also explains how weather and climate can be a metaphor for the brain. Dr. Raison is the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families at the University of Wisconsin School of Human Ecology. After the conclusion to our discussion on ketamine, Dr. Renee Kohanski finds the psychiatric nuggets from the remarkable film, Three Identical Strangers.

Is ketamine the anti-PTSD? In this edition of the MDedge Psychcast, Charles L. Raison, MD, discusses the possible impacts that ketamine and other psychedelic drugs have on specific mental illnesses. Dr. Raison is the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families at the University of Wisconsin School of Human Ecology.

In this edition of the MDedge Psychast, Lorenzo Norris, MD, welcomes Leslie Citrome, MD, of New York Medical College in Valhalla, NY. for a conversation on the challenges of TD. Sanjay Gupta, MD, of the University of Buffalo, spoke in an MDedge video earlier this year on the importance of using the Abnormal Involuntary Movement Scale to screen for TD and treating the disorder with vesicular monoamine transporter-2 inhibitors. In the episode, Dr. Citrome notes that despite recent advances in pharmacological options, clinicians can be challenged by TD.